Matches in SemOpenAlex for { <https://semopenalex.org/work/W4311752802> ?p ?o ?g. }
Showing items 1 to 73 of
73
with 100 items per page.
- W4311752802 abstract "Abstract Background GSK’s measles-mumps-rubella (MMR) vaccine is indicated for active immunization of individuals aged 12 months and older against these 3 serious illnesses. It is licensed in > 100 countries worldwide not including the US. In clinical trials, it elicited robust immune responses in children and was well tolerated. Monitoring the vaccine’s real-world safety profile in the general population continues, and rapid collection of data on its real-world use is a strength of passive safety surveillance. We provide an overview of the postmarketing spontaneous safety data over 24 years for GSK’s MMR vaccine. Methods Spontaneous adverse events (AE) reports following vaccination with GSK’s MMR vaccine were collected from GSK’s Global Safety Database from 4-December-1997 until 1-March-2022. Annual reporting trends for pyrexia, rashes (commonly reported in the pediatric population), and events of clinical interest like febrile convulsions and neurological conditions were analyzed from 1998 until 2021. The patient exposure was estimated by the number of doses distributed (DD). Results Over the reviewed period, ∼445 million doses of GSK’s MMR vaccine were distributed worldwide, and 29,504 cases were spontaneously reported (rate: 6.63 cases reported/100,000 DD). Of all spontaneous AE reports, 9,960 (33.76%) were considered as serious. For the period analyzed, pyrexia and rash were the most frequently reported AEs following vaccination with GSK’s MMR vaccine (Table). Reports of febrile convulsions had a mean frequency of 0.27 cases/100,000 DD (Table); reports of neurological conditions (encephalitis and/or panencephalitis and/or meningitis and/or meningism) had a mean frequency of 0.07 cases/100,000 DD (Table) and did not show a trend of increased incidence over time. Conclusion The postmarketing safety data analyzed showed that the safety profile of GSK’s MMR vaccine is consistent with that observed in clinical trials and remains supportive of its overall safety profile in routine use. GSK continues monitoring the safety of its MMR vaccine. Funding GlaxoSmithKline Biologicals SA Acknowledgment: Adina Truta/Julie Mellery provided medical writing/editorial support (Modis c/o GSK) Disclosures Tina Singh, MD physician, GSK: Employee of the GSK group of companies and having restricted GSK shares in the GSK group of companies Giacomo Casabona, MD, GSK: I’m an employee of the GSK group of companies and shareholder in the GSK group of companies Remon Abu-Elyazeed, MD, PhD, GSK: Employee of the GSK group of companies and having GSK stocks in the GSK group of companies Volker Vetter, MD, GSK: I’m an employee of the GSK group of companies and hold shares in the GSK group of companies Fanny Hergibo, Pharm.D., GSK: Employee of the GSK group of companies." @default.
- W4311752802 created "2022-12-28" @default.
- W4311752802 creator A5019710346 @default.
- W4311752802 creator A5026679113 @default.
- W4311752802 creator A5058710742 @default.
- W4311752802 creator A5070130007 @default.
- W4311752802 creator A5091622015 @default.
- W4311752802 date "2022-12-01" @default.
- W4311752802 modified "2023-09-30" @default.
- W4311752802 title "571. A Report of the Postmarketing Spontaneous Safety Data over 24 Years for GSK’s Measles-Mumps-Rubella (MMR) Vaccine" @default.
- W4311752802 doi "https://doi.org/10.1093/ofid/ofac492.624" @default.
- W4311752802 hasPublicationYear "2022" @default.
- W4311752802 type Work @default.
- W4311752802 citedByCount "0" @default.
- W4311752802 crossrefType "journal-article" @default.
- W4311752802 hasAuthorship W4311752802A5019710346 @default.
- W4311752802 hasAuthorship W4311752802A5026679113 @default.
- W4311752802 hasAuthorship W4311752802A5058710742 @default.
- W4311752802 hasAuthorship W4311752802A5070130007 @default.
- W4311752802 hasAuthorship W4311752802A5091622015 @default.
- W4311752802 hasBestOaLocation W43117528021 @default.
- W4311752802 hasConcept C126322002 @default.
- W4311752802 hasConcept C187212893 @default.
- W4311752802 hasConcept C197636746 @default.
- W4311752802 hasConcept C197934379 @default.
- W4311752802 hasConcept C203014093 @default.
- W4311752802 hasConcept C22070199 @default.
- W4311752802 hasConcept C2776438120 @default.
- W4311752802 hasConcept C2776646718 @default.
- W4311752802 hasConcept C2778570526 @default.
- W4311752802 hasConcept C2778814567 @default.
- W4311752802 hasConcept C2780801004 @default.
- W4311752802 hasConcept C2908647359 @default.
- W4311752802 hasConcept C2909545207 @default.
- W4311752802 hasConcept C57658597 @default.
- W4311752802 hasConcept C71924100 @default.
- W4311752802 hasConcept C8891405 @default.
- W4311752802 hasConcept C99454951 @default.
- W4311752802 hasConceptScore W4311752802C126322002 @default.
- W4311752802 hasConceptScore W4311752802C187212893 @default.
- W4311752802 hasConceptScore W4311752802C197636746 @default.
- W4311752802 hasConceptScore W4311752802C197934379 @default.
- W4311752802 hasConceptScore W4311752802C203014093 @default.
- W4311752802 hasConceptScore W4311752802C22070199 @default.
- W4311752802 hasConceptScore W4311752802C2776438120 @default.
- W4311752802 hasConceptScore W4311752802C2776646718 @default.
- W4311752802 hasConceptScore W4311752802C2778570526 @default.
- W4311752802 hasConceptScore W4311752802C2778814567 @default.
- W4311752802 hasConceptScore W4311752802C2780801004 @default.
- W4311752802 hasConceptScore W4311752802C2908647359 @default.
- W4311752802 hasConceptScore W4311752802C2909545207 @default.
- W4311752802 hasConceptScore W4311752802C57658597 @default.
- W4311752802 hasConceptScore W4311752802C71924100 @default.
- W4311752802 hasConceptScore W4311752802C8891405 @default.
- W4311752802 hasConceptScore W4311752802C99454951 @default.
- W4311752802 hasIssue "Supplement_2" @default.
- W4311752802 hasLocation W43117528021 @default.
- W4311752802 hasOpenAccess W4311752802 @default.
- W4311752802 hasPrimaryLocation W43117528021 @default.
- W4311752802 hasRelatedWork W2061108228 @default.
- W4311752802 hasRelatedWork W2066508216 @default.
- W4311752802 hasRelatedWork W2161755096 @default.
- W4311752802 hasRelatedWork W2744013110 @default.
- W4311752802 hasRelatedWork W2980518911 @default.
- W4311752802 hasRelatedWork W3173381452 @default.
- W4311752802 hasRelatedWork W4206537660 @default.
- W4311752802 hasRelatedWork W5169995 @default.
- W4311752802 hasRelatedWork W1850848669 @default.
- W4311752802 hasRelatedWork W2800436456 @default.
- W4311752802 hasVolume "9" @default.
- W4311752802 isParatext "false" @default.
- W4311752802 isRetracted "false" @default.
- W4311752802 workType "article" @default.